BEPRO TECHNOLOGY Trademark

Trademark Overview

On Friday, October 1, 2021, a trademark application was filed for BEPRO TECHNOLOGY with the United States Patent and Trademark Office. The USPTO has given the BEPRO TECHNOLOGY trademark a serial number of 97056902. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, July 8, 2025. This trademark is owned by Ligand Pharmaceuticals Incorporated. The BEPRO TECHNOLOGY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development of a process to deliver pharmaceutical preparations
bepro technology

General Information

Serial Number97056902
Word MarkBEPRO TECHNOLOGY
Filing DateFriday, October 1, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, July 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 16, 2022

Trademark Statements

Description of MarkThe mark consists of the letters "BEPRO" in a bold font with the letters "BEP" capitalized. The word "TECHNOLOGY" is written in lowercase lettering beneath "BEPRO". A stylized drawing of a chemical molecule is to the right of the wording "BEPRO TECHNOLOGY".
Pseudo MarkBE PRO TECHNOLOGY
NOT AVAILABLE"TECHNOLOGY"
Goods and ServicesPharmaceutical research and development of a process to deliver pharmaceutical preparations

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 28, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameLigand Pharmaceuticals Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameLigand Pharmaceuticals Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608

Trademark Events

Event DateEvent Description
Thursday, October 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 29, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, July 7, 2022NON-FINAL ACTION WRITTEN
Thursday, July 7, 2022NON-FINAL ACTION E-MAILED
Thursday, July 7, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, July 7, 2022EXAMINER'S AMENDMENT ENTERED
Tuesday, October 5, 2021NEW APPLICATION ENTERED
Friday, July 1, 2022ASSIGNED TO EXAMINER
Thursday, July 7, 2022EXAMINERS AMENDMENT -WRITTEN
Thursday, July 7, 2022EXAMINERS AMENDMENT E-MAILED
Thursday, July 7, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, July 14, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 27, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, April 10, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 9, 2023SOU EXTENSION 2 FILED
Monday, October 9, 2023SOU EXTENSION 2 GRANTED
Wednesday, October 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 16, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 16, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 11, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, April 10, 2023SOU EXTENSION 1 FILED
Monday, April 10, 2023SOU EXTENSION 1 GRANTED
Wednesday, April 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 9, 2023SOU TEAS EXTENSION RECEIVED
Friday, April 5, 2024SOU TEAS EXTENSION RECEIVED
Friday, April 5, 2024SOU EXTENSION 3 FILED
Friday, April 5, 2024SOU EXTENSION 3 GRANTED
Saturday, April 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 27, 2024SOU TEAS EXTENSION RECEIVED
Friday, September 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 27, 2024SOU EXTENSION 4 FILED
Friday, September 27, 2024SOU EXTENSION 4 GRANTED
Wednesday, March 12, 2025SOU EXTENSION 5 FILED
Tuesday, July 8, 2025SOU EXTENSION 5 GRANTED
Tuesday, July 8, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 9, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 13, 2025SOU TEAS EXTENSION RECEIVED

Related Keywords

technology bepro pharmaceutical preparations deliver development research process